Navigation Links
New treatment for muscle spasms

Stiff person syndrome (SPS) causes the muscles in the limbs and body to tighten up suddenly. Spasms can be triggered by noise, touch or emotional distress. People with the condition are often too disabled// to walk or move, or are afraid to leave the house in case they suffer a spasm and fall. The condition resembles chronic tetanus. Scientists have developed a highly effective treatment for this disorder of the nervous system which can leave people totally disabled.

Doctors have found that the symptoms can be relieved by giving patients an intravenous supply of a human protein called immunoglobulin (IVIg) designed to bolster the immune system. The success of the therapy supports the theory that SPS is caused by the immune system malfunctioning.

When this chemical is in short supply in the brain and spinal cord, the muscles are more likely to be over-stimulated and go into spasm. The scientists, led by Dr Marinos Dalakas, of the US National Institute of Neurological Disorders and Stroke, carried out tests on 23 patients with SPS. Half were started on IVIg therapy and then switched to a placebo, the rest began with a placebo but were then given IVIg.

In both cases, the patients had significantly less problems with stiffness and spasms when they were taking the IVIg therapy. 19 of the 23 patients who finished the study became less stiff and more mobile, and were able to either walk unassisted, resume work activities, or remain upright without fear of falling. Dr Dalakas said IVIg could be a more practical way of treating SPS than the current medication, diazepam.


'"/>




Page: 1

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Now umbilical cord helps in stroke treatment.
4. Now AIDS treatment comes dirt-cheap
5. Breast cancer treatment to be determined by gene test
6. Hemopurifier may revolutionise AIDS treatment
7. New drug helps boost cancer treatment
8. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
9. Experimental treatment for Ebola Virus Shows promising results in mice
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. New dimension in the treatment of female sexual dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New treatment for muscle spasms

(Date:5/16/2008)...National HIV Vaccine Awareness Day, May,18, WASHI...x years into the,AIDS epidemic, someone is newly i...unday, May 18, HIV Vaccine Awareness Day, AIDS Act... Institute of Allergy and Infectious,Disease (NIAI...s everyone,to help end the AIDS epidemic by partic...
(Date:5/16/2008)...untsworth plc (LSE: HNT), "the Group",a leading i...nications,group headquartered in London, released ...Group,s performance in the first quarter 2008 (the...follows below., 15 May 2008, ...erim Management Statement, Record net ...
(Date:5/16/2008)... More in 2007, WASHINGTON, May 16 /PRNewswire-USN...cancer deaths, the National Cancer Institute (NCI)...in lung cancer research in 2007,according to upda...) today., The two other federal agencies with sig...isease Control and Prevention (CDC) and the,Depart...
(Date:5/16/2008)...Comprehensive Income increased 42% to $9.7 million... - 2007 Gross Margin of 76%, - Product Sales Back... million from $2.4 million as of December 31, 200...stCall/ -- Huiheng,Medical, Inc. ("Huiheng" or the...sed leader in the development, sales and support o...
Breaking Medicine News(10 mins):Health News:AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Lung Cancer Still Lowest in Federal Funding 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 3Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 4Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 5Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 6
...al neuroscientist of Vanderbilt University have de...n insight into neural circuits that play a role in... circuits that make us apply previously learned ru...-control. The researchers feel that the new use o...
... and recovery from exercise may be a successful pr...nd vagal activities balance the changes in heart r...s from France, who carried out the research to fin...udden deaths, are of the opinion that sudden death...
...d at Digestive Disease Week 2005, antidepressants ...Clinical depression, also known as unipolar depres...ike selective serotonin reuptake inhibitors (SSRIs...s research have shown that use of nonsteroidal ant...
...d a set of cells in the pancreas that are targeted...e 1. The researchers from University of Colorado a...earch is likely to change the study of diabetes au...nge the way other autoimmune diseases are studied....
Other Medicine News:
(Date:5/15/2008)...ch, a publishing and,information services company ...finds that investigative sites are required to lea... More than 75% of respondents to a recent,CenterWa... three or more,EDC systems. In addition, a majorit...aining had improved., State of the Clinical Trial...
(Date:5/15/2008)...Call/ -- Novavax, Inc. (Nasdaq:,NVAX) today announ...I/IIa,study of its pandemic influenza vaccine incl...able interim results from the first phase of the s... adult volunteers, were,reported in December 2007....s well tolerated and immunogenic at the 15 microgr...
(Date:5/15/2008)...tions Blue Cross Blue Shield of Michigan to W... HealthLeaders-InterStudy, NA...rs-InterStudy, the,leading provider of managed car... continues to stagnate in Michigan, Blue Cross Blu...all of its competitors to weather the,economic sto...
(Date:5/15/2008)... Genous, Boston Scientific,s ...eal-World Use of Genous, Stent,s Performance in P...l-Antiplatelet Ther...usNeich today announced,that multiple clinical dat...port the use of the company,s Genous Bio-engineere...
Breaking Medicine Technology:CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 4Lauren Marangell M D to Join Lilly 3B Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar 1723 1Lauren Marangell M D to Join Lilly 3B Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar 1723 2CRC Health Group Announces Acquisition of Durhams Structure House Weight Loss Facility 1721 1CRC Health Group Announces Acquisition of Durhams Structure House Weight Loss Facility 1721 2CRC Health Group Announces Acquisition of Durhams Structure House Weight Loss Facility 1721 3GrantAdler Shipping Novel Implantable Vascular Access Port 1719 1GrantAdler Shipping Novel Implantable Vascular Access Port 1719 2Eight Michigan HMOs Two Providers Take Top Honors for Quality Health Care 1717 1Eight Michigan HMOs Two Providers Take Top Honors for Quality Health Care 1717 2Eight Michigan HMOs Two Providers Take Top Honors for Quality Health Care 1717 3
...re-FirstCall/ --,Schering-Plough Corporation annou...ts novel oral thrombin receptor antagonist (TRA),S...entific Sessions,of the of Cardiology (ACC.07)/Inn...n New Orleans. The Phase II trial, referred to,as ...oronary,Intervention (TRA-PCI) trial, has been acc...
...an TNFa, LAUSANNE, Switzerland, March 12, 2007 /PR...al independent biopharmaceutical,development compa...nditions, announces the presentation of preclinica... Debio-0512 as an anti-TNFa,therapeutic vaccine, t...ls of acute and chronic inflammation. Debio-0512 i...
Other Medicine Technology:Schering-Plough Announces Presentation of Phase II Trial Results,for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual,Meeting of The American College of Cardiology/i2 Summit 2Preclinical Update - Debio-0512 Therapeutic Vaccine for the,Treatment of Chronic and Acute Inflammatory Conditions 2
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
...ecial order products are offered as 1-piece or mod...r instruments may be customized with handles of ch...n and flush ports. Many standard patterns are avai... may affect delivery times. , Please Note: Indiv...
...ecial order products are offered as 1-piece or mod...r instruments may be customized with handles of ch...n and flush ports. Many standard patterns are avai... may affect delivery times. , Please Note: Indiv...
Medicine Products: